These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22577174)

  • 21. MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells.
    Zheng Z; Xu PP; Wang L; Zhao HJ; Weng XQ; Zhong HJ; Qu B; Xiong J; Zhao Y; Wang XF; Janin A; Zhao WL
    J Exp Clin Cancer Res; 2017 Jun; 36(1):82. PubMed ID: 28637496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autologous endothelial cell:peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics.
    Reed DM; Paschalaki KE; Starke RD; Mohamed NA; Sharp G; Fox B; Eastwood D; Bristow A; Ball C; Vessillier S; Hansel TT; Thorpe SJ; Randi AM; Stebbings R; Mitchell JA
    FASEB J; 2015 Jun; 29(6):2595-602. PubMed ID: 25746794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodies.
    Bailey L; Moreno L; Manigold T; Krasniqi S; Kropshofer H; Hinton H; Singer T; Suter L; Hansel TT; Mitchell JA
    J Pharmacol Toxicol Methods; 2013; 68(2):231-239. PubMed ID: 23280407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of T-cell cytokine production by ICOS-B7H2 interactions at the human fetomaternal interface.
    Nagamatsu T; Barrier BF; Schust DJ
    Immunol Cell Biol; 2011 Mar; 89(3):417-25. PubMed ID: 20733594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.
    Elsayed A; Pellegrino C; Plüss L; Peissert F; Benz R; Ulrich F; Thorhallsdottir G; Plaza SD; Villa A; Mock J; Puca E; De Luca R; Manz MG; Halin C; Neri D
    MAbs; 2023; 15(1):2220839. PubMed ID: 37288872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis.
    O'Dwyer R; Kovaleva M; Zhang J; Steven J; Cummins E; Luxenberg D; Darmanin-Sheehan A; Carvalho MF; Whitters M; Saunders K; Barelle CJ
    J Immunol Res; 2018; 2018():4089459. PubMed ID: 30417018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7h triggering inhibits the migration of tumor cell lines.
    Dianzani C; Minelli R; Gigliotti CL; Occhipinti S; Giovarelli M; Conti L; Boggio E; Shivakumar Y; Baldanzi G; Malacarne V; Orilieri E; Cappellano G; Fantozzi R; Sblattero D; Yagi J; Rojo JM; Chiocchetti A; Dianzani U
    J Immunol; 2014 May; 192(10):4921-31. PubMed ID: 24729612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.
    Tabares P; Berr S; Römer PS; Chuvpilo S; Matskevich AA; Tyrsin D; Fedotov Y; Einsele H; Tony HP; Hünig T
    Eur J Immunol; 2014 Apr; 44(4):1225-36. PubMed ID: 24374661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. After TGN1412: recent developments in cytokine release assays.
    Stebbings R; Eastwood D; Poole S; Thorpe R
    J Immunotoxicol; 2013; 10(1):75-82. PubMed ID: 22967038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
    McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
    J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICOS contributes to T cell expansion in CTLA-4 deficient mice.
    van Berkel ME; Schrijver EH; Hofhuis FM; Sharpe AH; Coyle AJ; Broeren CP; Tesselaar K; Oosterwegel MA
    J Immunol; 2005 Jul; 175(1):182-8. PubMed ID: 15972646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1.
    de Haij S; Woltman AM; Trouw LA; Bakker AC; Kamerling SW; van der Kooij SW; Chen L; Kroczek RA; Daha MR; van Kooten C
    Kidney Int; 2005 Nov; 68(5):2091-102. PubMed ID: 16221208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody Efalizumab.
    Kuschei WM; Leitner J; Majdic O; Pickl WF; Zlabinger GJ; Grabmeier-Pfistershammer K; Steinberger P
    Clin Immunol; 2011 May; 139(2):199-207. PubMed ID: 21414849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis of peripheral T cells in rodent cardiac allograft recipients induced by donor-specific transfusion with impaired inducible costimulator/B7 homologous protein allorecognition.
    Du JF; Shen XF; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
    Transplant Proc; 2013 Mar; 45(2):564-8. PubMed ID: 23498793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals.
    Leitner J; Drobits K; Pickl WF; Majdic O; Zlabinger G; Steinberger P
    Immunol Lett; 2011 Oct; 140(1-2):74-80. PubMed ID: 21756939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
    Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
    Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.
    Gigliotti CL; Boggio E; Clemente N; Shivakumar Y; Toth E; Sblattero D; D'Amelio P; Isaia GC; Dianzani C; Yagi J; Rojo JM; Chiocchetti A; Boldorini R; Bosetti M; Dianzani U
    J Immunol; 2016 Nov; 197(10):3905-3916. PubMed ID: 27798154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models.
    Hanson A; Elpek K; Duong E; Shallberg L; Fan M; Johnson C; Wallace M; Mabry GR; Sazinsky S; Pepper L; Shu CJ; Sathyanarayanan S; Zuerndorfer S; Simpson T; Gostissa M; Briskin M; Law D; Michaelson J; Harvey CJ
    PLoS One; 2020; 15(9):e0239595. PubMed ID: 32970735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.
    Sakamoto S; Tezuka K; Tsuji T; Hori N; Tamatani T
    Hybrid Hybridomics; 2001; 20(5-6):293-303. PubMed ID: 11839247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.